SCHEMBL23704727

SCHEMBL23704727

C[C@H](CCC(=O)OCOC(=O)CCC(CP(=O)(O)O)C(=O)O)C1CCC2C3CCC4C[C@H](O)CC[C@]4(C)C3C[C@H](O)[C@@]21C

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.70
▸ MAPK1 P28482 3/20 0.70
▸ MEN1 O00255 2/20 0.70
▸ KMT2A Q03164 2/20 0.70
▸ USP2 O75604 2/20 0.70
▸ LMNA P02545 1/20 0.70
▸ GPBAR1 Q8TDU6 9/20 0.68
▸ SLC10A2 Q12908 2/20 0.68
▸ NR1H4 Q96RI1 2/20 0.68
▸ TBXA2R P21731 1/20 0.68
▸ PDE3A Q14432 1/20 0.68
▸ CA1 P00915 2/20 0.60
▸ CA2 P00918 2/20 0.60
▸ ABCC4 O15439 1/20 0.56
▸ HIF1A Q16665 2/20 0.55
▸ VDR P11473 2/20 0.55
▸ CYP2C9 P11712 1/20 0.55
▸ CYP3A4 P08684 3/20 0.53
▸ SLCO1B3 Q9NPD5 1/20 0.53
▸ SLCO1B1 Q9Y6L6 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23710352 1.00 MAPT (0.70) MAPTMAPK1MEN1KMT2AUSP2
SCHEMBL23704741 1.00 MAPT (0.70) MAPTMAPK1MEN1KMT2AUSP2
SCHEMBL23710351 1.00 MAPT (0.70) MAPTMAPK1MEN1KMT2AUSP2
SCHEMBL23710353 1.00 MAPT (0.70) MAPTMAPK1MEN1KMT2AUSP2
SCHEMBL23704728 1.00 MAPT (0.70) MAPTMAPK1MEN1KMT2AUSP2
SCHEMBL23704700 0.94 GPBAR1 (0.69) MAPTMAPK1MEN1KMT2AUSP2
SCHEMBL23710358 0.94 GPBAR1 (0.69) MAPTMAPK1MEN1KMT2AUSP2
SCHEMBL23704698 0.94 GPBAR1 (0.69) MAPTMAPK1MEN1KMT2AUSP2
SCHEMBL26423896 0.93 MAPT (0.69) MAPTMAPK1MEN1KMT2AUSP2
SCHEMBL26423889 0.93 MAPT (0.69) MAPTMAPK1MEN1KMT2AUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4097119-B1 BILE ACID-GCPII INHIBITOR CONJUGATES TO TREAT INFLAMMATORY DISEASES UNIV JOHNS HOPKINS (US) 2025-05-07 — — EP disclosed
EP-4097119-A1 BILE ACID-GCPII INHIBITOR CONJUGATES TO TREAT INFLAMMATORY DISEASES The Johns Hopkins University (US) 2022-12-07 — — EP disclosed
WO-2021155167-A1 BILE ACID-GCPII INHIBITOR CONJUGATES TO TREAT INFLAMMATORY DISEASES THE JOHNS HOPKINS UNIVERSITY (US) 2021-08-05 — — WO disclosed
Send feedback